Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-008747
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2041694z10-k.txt 10-K 227050
2 EXHIBIT 10.3 a2041694zex-10_3.txt EX-10.3 18105
3 EXHIBIT 10.7 a2041694zex-10_7.txt EX-10.7 27289
4 EXHIBIT 10.57 a2041694zex-10_57.txt EX-10.57 43360
5 EXHIBIT 10.68 a2041694zex-10_68.txt EX-10.68 759223
6 EXHIBIT 10.69 a2041694zex-10_69.txt EX-10.69 113767
7 EXHIBIT 10.70 a2041694zex-10_70.txt EX-10.70 37309
8 EXHIBIT 23.1 a2041694zex-23_1.txt EX-23.1 1378
  Complete submission text file 0000912057-01-008747.txt   1229769
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6508120585
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21643 | Film No.: 1585202
SIC: 8731 Services-Commercial Physical & Biological Research